Research Title: A Phase III Double-Blind, Parallel Group, Multicenter Study to Compare the Efficacy and Safety of Xlucane Versus Lucentis® in Patients with Neovascular Age-Related Macular Degeneration (XPLORE).
Sponsor: Xbrane BioPharma AB
Principal Investigator: Atul Sharma, M.D.
Description: The objectives of this study are to demonstrate the equivalence of Xlucane to Lucentis® in treatment of subjects with wet (i.e., neovascular) age-related macular degeneration (wAMD).
Start Date: June 2019
Project Personnel: Leslie Marcus, CCRC; Caitlin Harrison, CCRC, COA; Stephanie Campbell, CRC, COA
Location(s): Marietta; 833 Campbell Hill Street, Suite 300, Marietta, GA 30060